Korro Bio (KRRO) Change in Account Payables (2018 - 2026)

Korro Bio (KRRO) has 9 years of Change in Account Payables data on file, last reported at -$153000.0 in Q1 2026.

• Quarterly Change in Account Payables fell 254.55% year-over-year to -$153000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 290.84% YoY) and the FY2025 annual result came in at -$2.3 million, down 72.33% from the prior year.
• Change in Account Payables advanced to -$153000.0 in Q1 2026, from -$637000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.8 million in Q4 2023 to a low of -$2.9 million in Q3 2025.
• A 5-year average of $61764.7 and a median of -$153000.0 in 2026 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2024 — Change in Account Payables jumped 1128.71% — and 2025, when it sank 1152.4%.
• Tracing KRRO's Change in Account Payables over 5 years: stood at $1.3 million in 2022, then surged by 115.35% to $2.8 million in 2023, then sank by 121.68% to -$605000.0 in 2024, then fell by 5.29% to -$637000.0 in 2025, then surged by 75.98% to -$153000.0 in 2026.
• The last three Change in Account Payables figures came in at -$153000.0 (Q1 2026), -$637000.0 (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.